Chong Kun Dang Pharmaceutical Corp. (185750) Stock Statistics & Valuation Metrics

Chong Kun Dang Pharmaceutical Corp. has a market cap or net worth of ₩889.38B. The enterprise value is $1.26M.

Chong Kun Dang Pharmaceutical Corp. has 13,802,780 shares outstanding. The number of shares has decreased by -2.65% in one year.

Chong Kun Dang Pharmaceutical Corp.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.30%.

The current PE Ratio of Chong Kun Dang Pharmaceutical Corp. is 11.3. Chong Kun Dang Pharmaceutical Corp.’s PEG ratio is -0.50.

In the last 12 months, Chong Kun Dang Pharmaceutical Corp. had revenue of 1.69T and earned 77.83B in profits. Earnings per share was 5.88K.

In the last 12 months, operating cash flow was 85.93B and capital expenditures -198.68B, giving a free cash flow of -112.75B billion.

Chong Kun Dang Pharmaceutical Corp. pays an annual dividend of ―, resulting in a dividend yield of ―

Chong Kun Dang Pharmaceutical Corp. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

Chong Kun Dang Pharmaceutical Corp. as a current ratio of 2.12, with Debt / Equity ratio of 35.86%

In the past 12 months, Chong Kun Dang Pharmaceutical Corp. has paid 3.83B in taxes.

Chong Kun Dang Pharmaceutical Corp. EV to EBITDA ratio is 9.92, with an EV/FCF ratio of -16.92.

Chong Kun Dang Pharmaceutical Corp. has ₩285.23B in cash and marketable securities with ₩368.00B in debt, giving a net cash position of -₩82.78B billion.

Gross margin is 29.65%, with operating margin of 4.76%, and net profit margin of 4.60%.

The average price target for Chong Kun Dang Pharmaceutical Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―